Eficacia del captopril y dinitrato de isosorbida en el manejo de urgencia hipertensiva
Contenido principal del artículo
Resumen
La urgencia hipertensiva es una condición médica grave para la cual existen diversos esquemas de abordaje cuyo objetivo es disminuir la presión arterial media en 20% o mantener la presión arterial diastólica por debajo de 120 mm Hg.
Detalles del artículo
Cómo citar
Referencias
ACC/AHA/NASPE 2001. The reduction of pressure of cardiovas- cular protection and bleed: a goal-analysis. Lancet 2001; 358: 1305-15.
Roberts JM, Redman CWG. Preclampsia: more than pregnancy- induced hypertension. Lancet 1993; 341: 1447-54 (Citation).
Grossman E, Ironi AN, Messerli FH. Comparative tolerability pro- file of hypertensive crisis treatments. Drug Safety 1998; 19: 99-122.
Ettinger WH Jr. Las bases farmacológicas de la terapéutica. In: Goodman & Gilman, Vol. I. México: McGraw Hill Interamericana; 2001, p. 885-90.
Varon J, Marik PE. The Diagnosis and Management of Hypertensi- ve Crises. Review.
Curie R. Managing hypertensive urgencies in primary care. Lippincott's Primary Care Practice; 1998: p. 495-504.
Millar-Craig MW, Bishop CN, Rafter EB. Circadian variation of blood pressure. Lancet 1999; 2: 795-7.
Beet L, Michel JR, Shiner LB. Pharmacokinetics: the dynamics of drug absorption, distribution, and elimination. In: Goodman Gimnan's. The pharmacological basis of therapeutics. 8th ed. New York: McGraw Hill; 2001, p. 3-33.
Hypertension detection and Follow up Program's Persistence of re- duction in blood pressure and mortality in participants in the hyperten- sion Detection and Follow up Program. JAMA 2002; 259: 2113-22.
Kaplan NM. Clinical hypertension. 6th ed. Baltimore: Williams an Wilkins; 2001.
Briston JD, Honour AJ, Pickering TG, Sleight P. Cardiovascular and respiratory changes during sleep in normal hypertensive subjects. Cardiovac Med 2000; 3: 476-86.
Ferguson RK, Vlasses PH. Hypertensive emergencies and urgen- cies. JAMA 2001; 255: 1607-12.
Oates JA. Antihypertensive agents and the drug therapy of hyper- tension. In: Goodman and Gilman's. The pharmacological basis of thera- peutics. 9th ed. Philadelphia: McGraw Hill; 2001, p. 780-8.
O'Brien EO, Owens P. Ambulatory blood pressure in the hyper- tensive population: Patterns and prevalence of hypertensive subforms. J Hypertens 2002; 16: 1735-43.
Tintinalli JE. Emergency medicine, international. Fifth edition. 2000, p. 402-5.
Niskanen L, Hedner T, Hansson L, Lanke E, et al. The reduced cardiovascular morbidity and mortality in hypertensive the diabetic pa- tients in the therapy of the first line with an inhibitor of comparative ACE with a regime of the diuretic/beta-blocker-baser. Treatment: A subanaly- sis of the captopril prevention project. www.americanheart.org/NASPE- www.naspe.org.
The sixth report of the Joint National Committee of Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch In- tern Med 1997; 157: 2413-46 (Abstract).
Chávez RI. Manual de urgencias cardiovasculares. Instituto Na- cional de Cardiología Ignacio Chávez. México: McGraw Hill Interameri- cana; 1999, p. 179-85.
Lemus A. Farmacología básica y clínica. México: Manual Moder- no; 2001, 214-20.
Anderson PO. Clinical drug data handbook of. 2003; 397-8.
Guadalajara JF. Cardiología 1998; 598-9.
Rubio GAF, Vargas AG. Comparación entre captopril sublingual e isosorbida para el manejo de crisis hipertensivas. Rev Mex Cardiol 1998;
(3): 81-5.
Manual de terapéutica médica. 4ª. Ed., México: McGraw Hill In- teramericana; p. 88.96.